Bristol Abilify “Approvable” For Bipolar Acute Mania
Bristol-Myers Squibb/Otsuka's Abilify (aripiprazole) is "approvable" for the treatment of acute mania in bipolar disorder, Bristol said during its first quarter earnings call April 28
Bristol-Myers Squibb/Otsuka's Abilify (aripiprazole) is "approvable" for the treatment of acute mania in bipolar disorder, Bristol said during its first quarter earnings call April 28